These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4772018)

  • 21. [Physico-chemical properties of dextran].
    Hint H
    Anesth Analg (Paris); 1976; 3(4):487-93. PubMed ID: 1015635
    [No Abstract]   [Full Text] [Related]  

  • 22. BLOOD SUBSTITUTES FOR TRANSFUSION.
    WALKER WF
    Practitioner; 1965 Aug; 195():187-92. PubMed ID: 14328858
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of various colloid infusion fluids in lactate - Ringer solutions in man].
    Yamasaki H
    Masui; 1974 Sep; 23(9):812-23. PubMed ID: 4475134
    [No Abstract]   [Full Text] [Related]  

  • 24. [Animal experimental studies on the effect of colloidal plasma substitutes in canine hemorrhagic shock].
    Lutz H
    Z Gesamte Exp Med Einschl Exp Chir; 1968 Apr; 146(4):383-96. PubMed ID: 5671891
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparison of dextran and gelatin as plasma substitutes].
    Lundsgaard-Hansen P; Riedwyl H; Hässig A
    Anaesthesist; 1967 Jul; 16(7):206-15. PubMed ID: 4872538
    [No Abstract]   [Full Text] [Related]  

  • 26. [Gelatin polymerization vs. low molecular weight dextran (gasometric and hemodynamic variations in cesarean section)].
    Pérez Tamayo L; Orozco Valdez G; Almaráz Ugalde A
    Ginecol Obstet Mex; 1975 Nov; 38(229):391-401. PubMed ID: 1205182
    [No Abstract]   [Full Text] [Related]  

  • 27. Coagulation, hemostasis, and plasma expanders:a quarter century enigma.
    Alexander B; Odake K; Lawlor D; Swanger M
    Fed Proc; 1975 May; 34(6):1429-40. PubMed ID: 47813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The determinants of the efficacy of various expanders in plasma volume expansion and maintenance in normal subjects.
    METCALF W; ROUSSELOT LM; HARMON JM; GILBERTSON FE
    Surg Forum; 1953 Oct; 4():714-9. PubMed ID: 13187372
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of plasma substitutes on blood viscosity and red cell agglutination].
    Takayanagi M; Oda T; Hatakeda A; Fukuchi H; Hase H
    Masui; 1971 Sep; 20(10):951-2. PubMed ID: 5166809
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of efficacy of dextran, oxypolygelatin, plasma and saline as plasma volume expanders.
    RAISZ LG; PULASKI EJ
    Am J Physiol; 1952 May; 169(2):475-82. PubMed ID: 14933615
    [No Abstract]   [Full Text] [Related]  

  • 31. Dextran, oxypolygelatin and modified fluid gelatin as replacement fluids in experimental hemorrhage.
    PARKINS WM; PERLMUTT JH; VARS HM
    Am J Physiol; 1953 Jun; 173(3):403-10. PubMed ID: 13065463
    [No Abstract]   [Full Text] [Related]  

  • 32. The clinical status of dextran, PVP and gelatin products.
    PULASKI EJ
    Int Rec Med Gen Pract Clin; 1952 Aug; 165(8):172-9. PubMed ID: 13010904
    [No Abstract]   [Full Text] [Related]  

  • 33. [MEASURES FOR THE PREVENTION OF HEPATITIS AFTER BLOOD TRANSFUSION, WITH SPECIAL REFERENCE TO PLASMA SUBSTITUTES].
    MIZUMO A
    Naika; 1964 Jul; 14():71-5. PubMed ID: 14174360
    [No Abstract]   [Full Text] [Related]  

  • 34. Pressure changes in the pulmonary trunk produced by volume substitutes with different viscosity following unilateral pulmonary exclusion.
    Hartel W; Schülke K
    Bibl Haematol; 1969; 33():357-63. PubMed ID: 5384004
    [No Abstract]   [Full Text] [Related]  

  • 35. [CONSIDERATIONS ON THE UTILITY OF "PLASMA EXPANDERS" IN ANESTHESIA, WITH PARTICULAR REGARD FOR A NEW GELATIN DERIVATIVE].
    RISTORI M; NOVELLI GP
    Ann Med Nav (Roma); 1965; 70():11-32. PubMed ID: 14269239
    [No Abstract]   [Full Text] [Related]  

  • 36. An assessment of the potential use of anionic dextrans as a plasma substitute.
    Chang RL; Crawford MP; West MD
    J Biomed Eng; 1980 Jan; 2(1):41-4. PubMed ID: 7359897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of watersoluble macromolecular compounds on natural and antibody sensitized erythrocytes. I. Studies on colloidal infusion solutions and some fractions of their poymers].
    Hummel K; Schmidt P
    Z Immunitatsforsch Allerg Klin Immunol; 1968 Apr; 135(2):164-87. PubMed ID: 4234996
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of plasma substitutes (dextran, polyvinylpyrrolidone and oxypolygelatin) with saline therapy in treatment of experimental tourniquet and burn shock in mice.
    MILLICAN RC; STOHLMAN EF; MOWRY RW
    Am J Physiol; 1952 Jul; 170(1):173-8. PubMed ID: 12985881
    [No Abstract]   [Full Text] [Related]  

  • 39. [A SIMPLE METHOD FOR MEASURING THE RELATIVE ONCOTIC EFFECTIVENESS OF COLLOIDAL PLASMA SUBSTITUTE SOLUTIONS].
    NITSCHMANN H; GYGAX HR
    Pathol Microbiol (Basel); 1964; 27():548-57. PubMed ID: 14178193
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma expanders.
    SELDON TH
    Curr Res Anesth Analg; 1954; 33(5):346-8. PubMed ID: 13210004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.